STING
activation
is
a
promising
application
therapeutic
strategy
for
cancer
immunotherapy.
In
particular,
MSA-2
as
an
oral
agonist
discovered
to
have
antitumor
activity.
However,
how
improve
the
effect
of
very
valuable
contribution
Here,
we
use
two
strategies
amplify
by
phospholipid
nanoparticles
delivering
mRNA
and
copper-modified
MSA-2.
We
synthesized
new
series
ionizable
optimized
nanoparticle
(1AP24)
mRNA,
increasing
expression
protein
bind
more
Second,
(MSA-2-Cu),
which
induced
cell
death
Cu2+
toxicity.
Combining
1AP24@STING
MSA-2-Cu
can
crucially
decrease
tumor
growth
increase
mouse's
survival.
It
treatment
through
amplifying
pathway.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 21, 2024
Overcoming
tumor
apoptosis
resistance
is
a
major
challenge
in
enhancing
cancer
therapy.
Pyroptosis,
lytic
form
of
programmed
cell
death
(PCD)
involving
inflammasomes,
Gasdermin
family
proteins,
and
cysteine
proteases,
offers
potential
treatment.
While
photodynamic
therapy
(PDT)
can
induce
pyroptosis
by
generating
reactive
oxygen
species
(ROS)
through
the
activation
photosensitizers
(PSs),
many
PSs
lack
specific
subcellular
targets
are
limited
to
first
near-infrared
window,
potentially
reducing
treatment
effectiveness.
Therefore,
developing
effective,
deep-penetrating,
organelle-targeted
pyroptosis-mediated
phototherapy
essential
for
strategies.
Here,
we
synthesized
four
molecules
with
varying
benzene
ring
numbers
thiopyrylium
structures
preliminarily
explore
their
properties.
The
near-infrared-II
(NIR-II)
PS
Z1,
higher
count,
exhibited
superior
ROS
generation
mitochondria-targeting
abilities,
large
Stokes
shift.
Through
nano-precipitation
method,
Z1
nanoparticles
(NPs)
also
demonstrated
high
(especially
type-I
ROS)
upon
808
nm
laser
irradiation,
leading
efficient
mitochondria
dysfunction
combined
apoptosis.
Moreover,
they
exceptional
tumor-targeting
ability
via
NIR-II
fluorescence
imaging
(NIR-II
FI)
photoacoustic
(PAI).
Furthermore,
NPs-mediated
effectively
inhibited
growth
minimal
adverse
effects.
Our
findings
offer
promising
strategy
therapy,
warranting
further
preclinical
investigations
PDT.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 3, 2024
Compared
with
conventional
therapies,
photoimmunotherapy
offers
precise
targeted
cancer
treatment
minimal
damage
to
healthy
tissues
and
reduced
side
effects,
but
its
efficacy
may
be
limited
by
shallow
light
penetration
the
potential
for
tumor
resistance.
Here,
an
acceptor-donor-acceptor
(A-D-A)-structured
nanoaggregate
is
developed
dual
phototherapy,
including
photodynamic
therapy
(PDT)
photothermal
(PTT),
triggered
single
near-infrared
(NIR)
light.
Benefiting
from
strong
intramolecular
charge
transfer
(ICT),
A-D-A-structured
nanoaggregates
exhibit
broad
absorption
extending
NIR
region
effectively
suppressed
fluorescence,
which
enables
deep
efficient
conversion
(η
=
67.94%).
A
suitable
HOMO-LUMO
distribution
facilitates
sufficient
intersystem
crossing
(ISC)
convert
ground-state
oxygen
(
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Nov. 30, 2024
In
the
realm
of
cancer
research,
tumor
microenvironment
(TME)
plays
a
crucial
role
in
initiation
and
progression,
shaped
by
complex
interactions
between
cells
surrounding
non-cancerous
cells.
Cytokines,
as
essential
immunomodulatory
agents,
are
secreted
various
cellular
constituents
within
TME,
including
immune
cells,
cancer-associated
fibroblasts,
themselves.
These
cytokines
facilitate
intricate
communication
networks
that
significantly
influence
initiation,
metastasis,
suppression.
Pyroptosis
contributes
to
TME
remodeling
promoting
release
pro-inflammatory
sustaining
chronic
inflammation,
impacting
processes
such
escape
angiogenesis.
However,
challenges
remain
due
interplay
among
cytokines,
pyroptosis,
along
with
dual
effects
pyroptosis
on
progression
therapy-related
complications
like
cytokine
syndrome.
Unraveling
these
complexities
could
strategies
balance
inflammatory
responses
while
minimizing
tissue
damage
during
therapy.
This
review
delves
into
crosstalk
elucidating
their
contribution
metastasis.
By
synthesizing
emerging
therapeutic
targets
innovative
technologies
concerning
this
aims
provide
novel
insights
enhance
treatment
outcomes
for
patients.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 6, 2025
The
tumor-specific
efficacy
of
the
most
current
anticancer
therapeutic
agents,
including
antibody-drug
conjugates
(ADCs),
oligonucleotides,
and
photosensitizers,
is
constrained
by
limitations
such
as
poor
cell
penetration
low
drug
delivery.
In
this
study,
we
addressed
these
challenges
developing,
a
positively
charged,
amphiphilic
Chlorin
e6
(Ce6)-conjugated,
cell-penetrating
anti-PD-L1
peptide
nanomedicine
(CPPD1)
with
enhanced
tissue
permeability.
CPPD1
molecule,
bioconjugate
hydrophobic
photosensitizer
strongly
charged
programmed
death-ligand
1
(PD-L1)
binding
(CPP),
capable
self-assembling
into
nanoparticles
an
average
size
199
nm
in
aqueous
solution
without
need
for
any
carriers.
These
carrier-free
possess
ability
to
penetrate
membrane
cancer
cells
target
tumors
expressing
PD-L1
on
their
surface.
Notably,
effectively
blocked
death-1
(PD-1)/PD-L1
interactions
reduced
expression
via
lysosomal
degradation.
They
also
demonstrated
responsiveness
photodynamic
therapy
(PDT)
635
laser,
leading
generation
ROS,
induction
various
immunogenic
deaths
(ICD).
Highly
penetrating
could
immunogenically
modulate
microenvironment
CT26
were
effective
treating
abscopal
metastatic
tumors,
addressing
major
traditional
PDT.
Journal of the American Chemical Society,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 24, 2025
Photodynamic
therapy
(PDT)
holds
promise
as
a
cancer
treatment
modality
due
to
its
potential
for
enhanced
precision
and
safety.
To
enhance
deep
tissue
penetration
minimize
adsorption
phototoxicity,
developing
photosensitizers
activated
by
second
near-infrared
window
(NIR-II)
light
shows
significant
potential.
However,
the
efficacy
of
PDT
is
often
impeded
tumor
microenvironment
hypoxia,
primarily
caused
irregular
vasculature.
Fortunately,
stimulator
interferon
genes
(STING)
pathway,
known
immune
activation,
has
been
linked
vasculature
normalization.
In
this
study,
we
developed
nanoplatform
(Fe-THBQ/SR)
loading
STING
agonist
(SR-717)
into
an
iron-tetrahydroxy-1,4-benzoquinone
(Fe-THBQ)
metal–organic
framework.
Fe-THBQ
was
proven
be
effective
NIR-II
photosensitizer,
generating
numerous
reactive
oxygen
species
(ROS)
under
1064
nm
laser
irradiation.
These
ROS
downregulated
heat
shock
protein
expression,
consequently
promoting
mild-photothermal
(mild-PTT),
facilitated
ferroptosis
depleting
glutathione
(GSH)/glutathione
peroxidase
4.
Moreover,
Fe-THBQ/SR
released
SR-717
upon
GSH
stimulation,
synergizing
with
ROS-mediated
double-stranded
DNA
leakage
activation.
This
process
contributed
normalization
hypoxia
alleviation,
thereby
enhancing
efficacy.
Overall,
presented
versatile
single-laser-triggered
mild-PTT
simultaneously
coupled
it
activation
form
reinforcing
cycle.
synergistic
enhancements
increased
immunogenicity
cells,
remodeled
immunosuppressive
microenvironment,
T
lymphocyte
infiltration,
improved
therapeutic
outcomes.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(22)
Published: May 1, 2024
Abstract
The
immunosuppressive
tumor
microenvironment
(ITME)
of
osteosarcoma
(OS)
poses
a
significant
obstacle
to
the
efficacy
existing
immunotherapies.
Despite
attempt
novel
immune
strategies
such
as
checkpoint
inhibitors
and
vaccines,
their
effectiveness
remains
suboptimal
due
inherent
difficulty
in
mitigating
ITME
simultaneously
from
both
system.
promotion
anti‐tumor
immunity
through
induction
immunogenic
cell
death
activation
cGAS‐STING
pathway
has
emerged
potential
counter
stimulate
systemic
antitumor
responses.
Here,
bimetallic
polyphenol‐based
nanoplatform
(Mn/Fe‐Gallate
nanoparticles
coated
with
membranes
is
presented,
MFG@TCM)
which
combines
mild
photothermal
therapy
(PTT)
for
reversing
via
inducing
pyroptosis
OS
cells
activating
dendritic
(DCs).
immunostimulatory
pathways,
syngeneic
effect,
exerted
substantial
positive
impact
on
promoting
secretion
damage‐associated
molecular
patterns
(DAMPs)
proinflammatory
cytokines,
favors
remodeling
microenvironment.
Consequently,
effector
T
led
notable
response,
effectively
inhibiting
growth
primary
distant
tumors.
This
study
proposes
new
method
treating
using
PTT
mudulation,
showing
promise
overcoming
current
treatment
limitations.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: May 12, 2024
Abstract
Zinc
oxide
nanoparticles
(ZnO
NPs)
stand
as
among
the
most
significant
metal
in
trigger
formation
of
reactive
oxygen
species
(ROS)
and
induce
apoptosis.
Nevertheless,
utilization
ZnO
NPs
has
been
limited
by
shallowness
short-wavelength
light
constrained
production
ROS.
To
overcome
these
limitations,
a
strategy
involves
achieving
red
shift
towards
near-infrared
(NIR)
spectrum,
promoting
separation
restraining
recombination
electron-hole
(e
−
-h
+
)
pairs.
Herein,
hybrid
plasmonic
system
Au@ZnO
(AZ)
with
graphene
quantum
dots
(GQDs)
doping
(AZG)
nano
heterostructures
is
rationally
designed
for
optimal
NIR-driven
cancer
treatment.
Significantly,
multifold
increase
ROS
generation
can
be
achieved
through
following
creative
initiatives:
(i)
Au
nanorods
expands
photocatalytic
capabilities
AZG
into
NIR
domain,
offering
foundation
NIR-induced
clinical
utilization;
(ii)
elaborate
design
mesoporous
core-shell
AZ
structures
facilitates
redistribution
pairs;
(iii)
incorporation
GQDs
structure
could
efficiently
restrain
e
(iv)
Modification
hyaluronic
acid
(HA)
enhance
CD44
receptor
mediated
targeted
triple-negative
breast
(TNBC).
In
addition,
introduced
NRs
present
catalysts
enhancing
photothermal
therapy
(PTT),
effectively
inducing
apoptosis
tumor
cells.
The
resulting
HA-modified
(AZGH)
exhibits
efficient
hot
electron
injection
separation,
affording
unparalleled
convenience
enabling
PDT
treanment.
As
result,
our
well-designed
AZGH
photosensitizers
exhibit
excellent
efficacy.
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
136(39)
Published: July 8, 2024
Abstract
Overcoming
tumor
apoptosis
resistance
is
a
major
challenge
in
enhancing
cancer
therapy.
Pyroptosis,
lytic
form
of
programmed
cell
death
(PCD)
involving
inflammasomes,
Gasdermin
family
proteins,
and
cysteine
proteases,
offers
potential
treatment.
While
photodynamic
therapy
(PDT)
can
induce
pyroptosis
by
generating
reactive
oxygen
species
(ROS)
through
the
activation
photosensitizers
(PSs),
many
PSs
lack
specific
subcellular
targets
are
limited
to
first
near‐infrared
window,
potentially
reducing
treatment
effectiveness.
Therefore,
developing
effective,
deep‐penetrating,
organelle‐targeted
pyroptosis‐mediated
phototherapy
essential
for
strategies.
Here,
we
synthesized
four
molecules
with
varying
benzene
ring
numbers
thiopyrylium
structures
preliminarily
explore
their
properties.
The
near‐infrared‐II
(NIR‐II)
PS
Z1,
higher
count,
exhibited
superior
ROS
generation
mitochondria‐targeting
abilities,
large
Stokes
shift.
Through
nano‐precipitation
method,
Z1
nanoparticles
(NPs)
also
demonstrated
high
(especially
type‐I
ROS)
upon
808
nm
laser
irradiation,
leading
efficient
mitochondria
dysfunction
combined
apoptosis.
Moreover,
they
exceptional
tumor‐targeting
ability
via
NIR‐II
fluorescence
imaging
(NIR‐II
FI)
photoacoustic
(PAI).
Furthermore,
NPs‐mediated
effectively
inhibited
growth
minimal
adverse
effects.
Our
findings
offer
promising
strategy
therapy,
warranting
further
preclinical
investigations
PDT.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 18, 2024
Abstract
Endocrine‐resistant
ER+HER2–
breast
cancer
(BC)
is
particularly
aggressive
and
leads
to
poor
clinical
outcomes.
Effective
therapeutic
strategies
against
endocrine‐resistant
BC
remain
elusive.
Here,
analysis
of
the
RNA‐sequencing
data
from
patients
receiving
neoadjuvant
endocrine
therapy
spatial
transcriptomics
both
show
downregulation
innate
immune
signaling
sensing
cytosolic
DNA,
which
primarily
occurs
in
cells,
not
cells.
Indeed,
compared
with
endocrine‐sensitive
activity
DNA
through
cGAS‐STING
pathway
attenuated
Screening
kinase
inhibitor
library
that
this
effect
mainly
mediated
by
hyperactivation
AKT1
kinase,
binds
domain
TBK1,
preventing
formation
a
trimeric
complex
TBK1/STING/IRF3.
Notably,
inactivation
cGAS–STING
forms
positive
feedback
loop
hyperactivated
promote
resistance,
physiologically
important
clinically
relevant
BC.
Blocking
using
combination
an
STING
agonist
results
engagement
adaptive
impairs
growth
tumors
humanized
mice
models,
providing
potential
strategy
for
treating